Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trialOsamu Aramaki, Masashi Fujii, Hidemori Sakamoto et al.|European Journal of Cancer|2021Cited by 24